Duan-Fang Liao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Duan-Fang Liao has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Fuchu He
State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Research Unit of Proteomics Driven Cancer Precision Medicine (Chinese Academy of Medical Sciences), Beijing, China
2 shared publications Hu-Jun Jiang
Division of Cell Biology, Genetics and Developmental Biology, Department of Life Science, National Natural Science Foundation of China, Beijing 100085, China
2 shared publicationsHui-Ling Yang
SNP Institute, Institute of Pharmacy and Pharmacology, Nanhua University, Hengyang 421001, Hunan, China
2 shared publicationsWei-Yi Fang
Cancer Research Institute, Center South University, Changsha 410078, Hunan, China
2 shared publicationsYang-Yan Xu
SNP Institute, Institute of Pharmacy and Pharmacology, Nanhua University, Hengyang 421001, Hunan, China
2 shared publicationsCui-Ming Zhu
Nanhua University
1 shared publication
Latest Publications
- 1 March 2005
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 328 (1) , 265-272
High fidelity PCR with an off/on switch mediated by proofreading polymerases combining with phosphorothioate-modified primer
- 1 March 2005
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 328 (1) , 265-272
High fidelity PCR with an off/on switch mediated by proofreading polymerases combining with phosphorothioate-modified primer
- 1 December 2003
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 15 (4) , 273-276
Binding and interaction of transcriptional regulator human Daxx with adenovirus12 E1B 55 kilodalton oncoprotein
Objective: To study the disruption of co-localization of human Daxx(hDaxx) with promyelocytic leukemia protein(PML) at the PML oncogenic domains (PODs) by the interaction of hDaxx with adenovirus(Ad) 12 E1B 55 Kilodalton Oncoprotein (Ad 12 E1B 55kD). Methods: The direct binding reaction of hDaxx and Ad12 E1B 55kD was analyzed by coimmunoprecipitation and Western blottingin vivo orin vitro. The interaction of hDaxx with Ad12 E1B 55kD was studied using yeast two-hybrid assay. Results: hDaxx bounded directly to Ad12 E1B 55kDin vivo andin vitro. hDaxx interacted with full length Ad12 E1B 55kD. Conclusion: Transcriptional regulator hDaxx directly binds to and interacts with Ad12 E1B 55kD.
- 1 December 2003
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 15 (4) , 273-276
Binding and interaction of transcriptional regulator human Daxx with adenovirus12 E1B 55 kilodalton oncoprotein
Objective: To study the disruption of co-localization of human Daxx(hDaxx) with promyelocytic leukemia protein(PML) at the PML oncogenic domains (PODs) by the interaction of hDaxx with adenovirus(Ad) 12 E1B 55 Kilodalton Oncoprotein (Ad 12 E1B 55kD). Methods: The direct binding reaction of hDaxx and Ad12 E1B 55kD was analyzed by coimmunoprecipitation and Western blottingin vivo orin vitro. The interaction of hDaxx with Ad12 E1B 55kD was studied using yeast two-hybrid assay. Results: hDaxx bounded directly to Ad12 E1B 55kDin vivo andin vitro. hDaxx interacted with full length Ad12 E1B 55kD. Conclusion: Transcriptional regulator hDaxx directly binds to and interacts with Ad12 E1B 55kD.